Metastatic prostate cancer cells frequently acquire cancer stem cell (CSC) properties, which result in self-renewal and chemoresistance (38, 39), therefore we examined the TCGA-PRAD cohort for any association of MALAT1 with self-renewal factors. This evidence concerns the gene MALAT1 and prostate adenocarcinoma.